Conversely, the levels of PD-L1+ tumor cells, or TAM-negative for PD-L1 and IDO were not associated with a bad outcome, suggesting that the immunophenotype of TAMs, rather than their quantity, can affect the survival of cHL patients. The gene discussed is CD274; the disease is classic Hodgkin lymphoma.